$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
Supply Issues Resolved for Eli Lilly's (LLY) Zepbound and Mounjaro
01:50am, Thursday, 03'rd Oct 2024
The U.S. Food and Drug Administration (FDA) has announced that the supply shortages of Eli Lilly's (LLY, Financial) popular weight-loss and diabetes medications, Zepbound and Mounjaro, have been resol
Eli Lilly (LLY) Solves U.S. Shortage of Mounjaro and Zepbound, Plans Major Expansion
08:11pm, Wednesday, 02'nd Oct 2024
The U.S. Food and Drug Administration (FDA) recently announced that the shortage of Eli Lilly's weight loss medications, Mounjaro and Zepbound, has been resolved. While these drugs, which contain tirz
US FDA says Lilly's weight-loss drug no longer in shortage
06:30pm, Wednesday, 02'nd Oct 2024
Eli Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro are no longer in shortage, the U.S. Food and Drug Administration's website showed on Wednesday.
3-Stock Lunch: Nike, Humana & Eli Lilly
03:07pm, Wednesday, 02'nd Oct 2024
Anthony Forcione, Rockland Trust VP, joins 'Power Lunch' to discuss stock plays for three stocks.
Eli Lilly CEO: We have 11 pipeline projects in obesity
11:29am, Wednesday, 02'nd Oct 2024
CNBC's Angelica Peebles joins 'Squawk on the Street' to report on Eli Lilly's new investment in a new $4.5 billion research and development center.
Eli Lilly Commits $4.5B To New Facility, Banking On Mounjaro, Zepbound's Weight Loss Success Despite Short-Term Stock Challenges
10:37am, Wednesday, 02'nd Oct 2024
Eli Lilly and Co LLY is making a major move with a $4.5 billion investment to create the Lilly Medicine Foundry, a new research and manufacturing facility.
3 Momentum Trades Too Good Pass Up
08:36am, Wednesday, 02'nd Oct 2024
Momentum investing is based on the idea that stocks that have risen recently will tend to keep rising and that stocks that have fallen tend to keep falling. In 1993, researchers Narasimhan Jegadeesh a
Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline
08:16am, Wednesday, 02'nd Oct 2024
CNBC's Angelica Peebles joins 'Squawk Box' with the latest news.
Lilly announces new $4.5 bln manufacturing site in Indiana
07:39am, Wednesday, 02'nd Oct 2024
U.S. drugmaker Eli Lilly said on Wednesday it will invest $4.5 billion to create a new center for advanced manufacturing and drug development in Indiana.
Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline
07:30am, Wednesday, 02'nd Oct 2024
Eli Lilly will invest $4.5 billion to construct the Lilly Medicine Foundry, a center aimed at finding better ways to make medicines. The investment seeks to build upon Lilly's success from Mounjaro an
Indiana facility will combine research, manufacturing and the latest technology to innovate new production methods and scale global access to clinical supply for Lilly's growing pipeline Opening in la
Is Trending Stock Eli Lilly and Company (LLY) a Buy Now?
10:05am, Monday, 30'th Sep 2024
Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.
Eli Lilly: Ebglyss To Challenge Dupixent In Atopic Dermatitis
09:35am, Monday, 30'th Sep 2024
Eli Lilly received FDA approval for Ebglyss for the treatment of moderate to severe atopic dermatitis this month. Ebglyss' efficacy looks comparable, if not slightly superior, to current market leader
The secrets to success that Microsoft, Meta, Lilly and Texas Instruments all share
07:20am, Monday, 30'th Sep 2024
The fundamentals of high-quality stocks, from a fund manager who handily beats the market.
5 Best CEFs This Month For 9% Plus Yield (September 2024)
09:30am, Sunday, 29'th Sep 2024
For income investors, closed-end funds remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. Closed-end funds, or CEFs,
Sign In
Buy LLY